The European Union’s Drug Watchdog said on Thursday that it would decide in early October whether a booster dose of the Pfizer / Bio-tech Covid-19 vaccine would be approved for those over 16 years of age.
According to the European Medicines Agency (EMA), more Jabs of Pfizer and Modern vaccines are to be decided at the same time for both at-risk and older adults.
Marco Cavalli, head of vaccine strategy at the Amsterdam-based regulatory body, told a news conference that protection against coronavirus had declined in the months following the first JAB.
“Early vaccinations have shown that protection against Covid-19 is declining over time, and protection against infections and symptoms in different parts of the world is declining,” Cavalleri said.
As a result, EMA is now evaluating Pfizer’s application for the use of a third booster dose six months after the second dose in 16-year-olds or older.
“The results of this assessment are expected in early October, even if supplementary information is not needed,” Cavalli said.